PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, 119991, Russia. vr.elmira@gmail.com.\', \'Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia. vr.elmira@gmail.com.\', \'Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, 119991, Russia.\', \'Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1038/s41598-021-90701-w
?:hasPublicationType
?:journal
  • Scientific reports
is ?:pmid of
?:pmid
?:pmid
  • 34045585
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.533
?:rankingScore_hIndex
  • 122
is ?:relation_isRelatedTo_publication of
?:title
  • Viral fibrotic scoring and drug screen based on MAPK activity uncovers EGFR as a key regulator of COVID-19 fibrosis.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all